Even so, treatment of AR-dependent cell lines with STO-609 has been shown to decrease their proliferation, migration, and invasion [13,121,123], indicating the viability of CAMKK2 as a potential target in PCa. The gene discussed is AR; the disease is posterior cortical atrophy.